Loading data for VTAK — first visit, this takes a few seconds.
Catheter Precision, Inc. (VTAK)
NYSE American: VTAK
· Real-Time Price · USD
0.20
+0.00 (0.00%)
At close: Sep 04, 2026, 8:00 PM
0.19
-7.33%
After-hours: 7:47 PM
The price, the headline numbers and the latest news, in one place.
Catheter Precision, Inc. (VTAK) Stock Price, Analysis & Data
No data available
| Bid | 0.2 |
| Market Cap | 758K |
| Revenue (ttm) | 1.92M |
| Net Income (ttm) | -13.6M |
| 0.47 | |
| -4.07 | |
| n/a | |
| -0.06 | |
| P/B (ttm) | 0.04 |
| P/S (ttm) | 0.40 |
| Earnings Date | n/a |
| Ask | 0.2 |
| Volume | 418,856 |
| Avg. Volume (20D) | 10,847,287 |
| Open | 0.20 |
| Previous Close | 0.20 |
| Day's Range | 0.20 - 0.20 |
| 52-Week Range | 0.19 - 3.20 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About VTAK
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a...
Industry Medical Devices
Sector Healthcare
IPO Date Sep 27, 2018
Employees 17
Stock Exchange NYSE American
Ticker Symbol VTAK
Financial Performance
In 2025, Catheter Precision's revenue was 819K, an increase of 95% compared to the previous year's 420K. Earnings were -17.18M, an increase of 3.24%.
Financial StatementsEarnings Surprise
Catheter Precision has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.